CDC Says US Will Transition to Trivalent Vaccines Next Flu Season
Drug Topics
MARCH 13, 2024
Since changes in vaccine composition can sometimes lead to confusion or misinformation, effective communication is crucial to promote vaccine uptake.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Drug Topics
MARCH 13, 2024
Since changes in vaccine composition can sometimes lead to confusion or misinformation, effective communication is crucial to promote vaccine uptake.
Drug Topics
FEBRUARY 15, 2024
Innovation in the vaccine area continues. In 2023, the FDA approved six vaccines, including several important firsts. But they face a difficult landscape where federal policies dictate coverage.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JANUARY 18, 2024
In 2023, the FDA approved six vaccines, including 2 for respiratory syncytial virus (RSV), and the first vaccine to prevent the mosquito-borne virus chikungunya.
STAT
JANUARY 25, 2024
A historic new study out of Scotland shows the real-world impact of vaccines against the human papillomavirus: The country has detected no cases of cervical cancer in women born between 1988-1996 who were fully vaccinated against HPV between the ages of 12 and 13.
STAT
MARCH 5, 2024
When Americans line up for flu vaccines next fall, they will almost certainly be getting vaccines that no longer contain protection against a family of flu viruses that appears to be extinct.
Drug Topics
NOVEMBER 24, 2023
Study authors recommend that healthcare personnel consider prioritizing influenza vaccination for patients with recent cardiovascular diseases (CVDs) in light of new evidence.
Drug Topics
JANUARY 5, 2024
A model showed that if a vaccine coverage of 66% were achieved—similar to flu vaccination coverage—it could have a budget impact of $6.48 billion over the first RSV season.
Drug Topics
DECEMBER 24, 2023
Vaccine approvals included two immunizations for RSV and a new pentavalent meningococcal shot.
Drug Topics
JANUARY 10, 2024
The estimated efficacy of the vaccine against documented infection for children and adolescents during the Omicron wave was 74.3% and 85.5%, respectively.
Drug Topics
FEBRUARY 13, 2024
Drug Topics talked with Gregg Sylvester, MD, chief health officer and vice president of medical affairs at CSL Seqirus, about what can we learn from this unique situation to improve future vaccine development and distribution.
Drug Topics
DECEMBER 14, 2023
While either vaccine offers some protection, having both vaccines offers the strongest level of protection against hospitalization and severe complications like MIS-C, and death.
Drug Topics
JANUARY 15, 2024
Data has indicated a potential association between COVID-19 vaccination and menstruation, but there is little evidence about this association based on chart-reviewed medical record data.
STAT
FEBRUARY 1, 2024
A study published in the CDC’s online journal Morbidity and Mortality Weekly Report showed that the updated vaccine was essentially equally effective at protecting against the strain targeted by the vaccine — called XBB.1.5 1 subvariant, which emerged after the vaccine was made. 1.5 — and the JN.1
Drug Topics
JANUARY 30, 2024
Findings from a recent study showed that participants who watched a video discussing COVID-19 vaccination had significantly higher knowledge scores compared to those who did not watch it.
STAT
FEBRUARY 27, 2024
An unprecedented shortage of cholera vaccine has public health experts fearing that a recent surge of outbreaks across developing countries will only worsen, a situation they argue is as regrettable as it was avoidable. Those numbers will almost certainly rise amid the worst vaccine shortage since an oral vaccine was introduced in the 1990s.
Drug Topics
MARCH 4, 2024
Study findings clarifying what to expect regarding the menstrual cycle after COVID-19 vaccination could help address low vaccine uptake.
Drug Topics
OCTOBER 30, 2023
Prophylactic HPV vaccines have demonstrated remarkable efficacy, exceeding 98%, and they are already proving to be effective in the prevention of anogenital warts, precancerous lesions, and cancer alike.
Drug Topics
JANUARY 17, 2024
A panel of clinicians gathered to address concerns and report preliminary findings around rates of RSV incidence, hospitalization, and vaccination.
Pharmacy Times
MARCH 6, 2024
This episode highlights how celebrity endorsements and local influencers can be leveraged to address vaccine hesitancy by shaping attitudes, but also must account for factors like audience trust and the potential for both benefits and limitations.
Drug Topics
JANUARY 3, 2024
The vaccine, called mRNA-1345, demonstrated an efficacy of 83.7% against RSV-associated lower respiratory tract disease with at least 2 signs or symptoms and 82.4% against the disease with at least 3 signs or symptoms.
STAT
JANUARY 21, 2024
LONDON — Starting Monday, a new, highly effective malaria vaccine will be rolled out for the first time, as an immunization campaign for children kicks off in Cameroon — a day that global health officials say marked a historic step in the decades-long quest to protect people from one of the world’s deadliest infections.
STAT
FEBRUARY 12, 2024
A new study has shown that people vaccinated against Ebola who still developed the disease had a substantially lower risk of dying than people who were not vaccinated, even if they received the vaccine when they were already infected with the virus. Read the rest…
STAT
SEPTEMBER 11, 2023
The Food and Drug Administration announced Monday that it had greenlit two updated Covid-19 booster shots in people as young as 6 months old, triggering a process that could see the Moderna and Pfizer-BioNTech vaccines become available in doctors’ offices, clinics, and pharmacies later this week. Read the rest…
STAT
FEBRUARY 15, 2024
The Department of Health and Human Services announced Thursday that it is filling eight vacancies, including the chairmanship, on an important advisory panel on vaccine policy that was down to less than half of its normal roster for months.
Drug Topics
JANUARY 16, 2024
Within a 12-month time frame, adjusted vaccine effectiveness against diagnosed long and probable long COVID was 41.7% and 35.4%, respectively.
STAT
FEBRUARY 28, 2024
has unveiled an advertising campaign aimed at boosting vaccination rates in children, which have steadily fallen over the past decade and took an even greater dip during the height of the Covid-19 pandemic. LONDON — Facing a growing outbreak of measles, the U.K.
pharmaphorum
JANUARY 10, 2024
Novavax is a leading pharmaceutical company dedicated to creating protein-based vaccines for diseases like COVID-19 and malaria. Learn more about their innovative vaccine development process and their commitment to creating a healthier future.
Drug Topics
OCTOBER 15, 2023
Goode, PharmD, director of the PGY1 Community Based Residency Program at Virginia Commonwealth University, discussed the new vaccine guidelines from ACIP. Jean-Venable R.
Drug Topics
MAY 19, 2023
Seasonal influenza kills hundreds of thousands of people every year due to a constantly changing virus and highly inefficient vaccine production. A universal flu vaccine could deal with the first problem, and mRNA technology with the second.
Drug Topics
FEBRUARY 14, 2023
The updated vaccine schedule includes vaccinations for influenza, pneumococcal disease, measles, mumps, and rubella (MMR) and COVID-19.
Drug Topics
NOVEMBER 10, 2023
Ixchiq contains a live, weakened version of the chikungunya virus and may cause symptoms in the vaccine recipient similar to those experienced by people who have chikungunya disease.
European Pharmaceutical Review
MARCH 14, 2024
Overall, the goal of expanded facility is to strengthen [SK biosciences] manufacturing capabilities for global supply [of the pneumococcal conjugate vaccine candidate GBP410]” SK bioscience has announced its manufacturing plant L HOUSE, in Andong, Gyeongsangbuk-do, South Korea, is set to have a facility expansion.
Pharmacy Times
DECEMBER 15, 2023
The proposed Vaccine Injury Compensation Modernization Act is intended to bring valuable updates to the 36-year-old legislation.
Drug Topics
NOVEMBER 16, 2023
VAERS was designed to collect reports of symptoms, diagnoses, hospital admissions, and deaths after vaccination for postmarket safety signals.
Drug Topics
NOVEMBER 2, 2023
Vaccination can combat this risk, but not all care workers get flu shots. Care home staff play a role in transmission to elderly residents by bringing flu in from their communities, especially in winter.
STAT
FEBRUARY 22, 2024
A Florida state policy set amid a measles outbreak in Broward County has vaccination proponents aghast, with many saying it leaves unvaccinated children especially vulnerable to the highly contagious disease.
STAT
JANUARY 22, 2024
America is over the Covid vaccine. Frantic lineups for scarce doses when Covid vaccines first became available have long since given way to widespread indifference. of Americans aged 18 and older and 11% of children have been vaccinated with the latest Covid vaccine. 6, a mere 21.5% 6, a mere 21.5% Read the rest…
Drug Topics
OCTOBER 31, 2023
The combination vaccine produced robust immune responses from vaccine candidates in a phase 1/2 clinical trial.
STAT
FEBRUARY 28, 2024
In a global first, some travelers and laboratory researchers who are at risk of contracting chikungunya will soon be allowed to be vaccinated against the virus. A committee of vaccine experts recommended Wednesday that those selective groups of people should be offered access to the new vaccine, Ixchiq, which is made by Valneva Austria GmbH.
Drug Topics
FEBRUARY 21, 2023
With nearly 250,000 kindergarten age children not receiving their recommended vaccines, pediatric health care providers search for solutions.
STAT
FEBRUARY 29, 2024
The new vaccines that protect older adults against respiratory syncytial virus, or RSV, may be linked to a small increased risk of developing Guillain-Barré syndrome, new data from the Centers for Disease Control and Prevention and the Food and Drug Administration suggest. Read the rest…
Drug Topics
OCTOBER 20, 2022
Adults who receive influenza and pneumococcal vaccines may be more likely to receive COVID-19 vaccines and boosters.
Med Ed 101
OCTOBER 25, 2023
The CDC has approved RSV vaccines for patients over the age of 60 and those who are pregnant. We provide an RSV vaccine comparison table below to help you recognize the differences between these vaccines and who may benefit from vaccination.
STAT
OCTOBER 3, 2023
The Food and Drug Administration on Tuesday authorized Novavax’s updated Covid-19 vaccine, giving Americans seeking to update their protection against the SARS-CoV-2 virus another option. based company, which has struggled to claim a share of the now dwindling Covid vaccine market — globally and within the United States.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content